相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Evaluation of an Epigenetic Assay for Predicting Repeat Prostate Biopsy Outcome in African American Men
Robert L. Waterhouse et al.
UROLOGY (2019)
The Immune Landscape of Prostate Cancer and Nomination of PD-L2 as a Potential Therapeutic Target
Shuang G. Zhao et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2019)
Cost-effectiveness of SelectMDx for prostate cancer in four European countries: a comparative modeling study
Tim M. Govers et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2019)
Prostate cancer screening: guidelines review and laboratory issues
Xavier Filella et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2019)
Multicenter Optimization and Validation of a 2-Gene mRNA Urine Test for Detection of Clinically Significant Prostate Cancer before Initial Prostate Biopsy
Alexander Haese et al.
JOURNAL OF UROLOGY (2019)
Serum and urinary biomarkers for detection and active surveillance of prostate cancer
Maria F. Becerra et al.
CURRENT OPINION IN UROLOGY (2019)
Extracellular vesicles as a novel source of biomarkers in liquid biopsies for monitoring cancer progression and drug resistance
M. Helena Vasconcelos et al.
DRUG RESISTANCE UPDATES (2019)
Clinical utility of the Prostate Health Index (phi) for biopsy decision management in a large group urology practice setting
Jay White et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2018)
Combining Prostate Health Index density, magnetic resonance imaging and prior negative biopsy status to improve the detection of clinically significant prostate cancer
Sasha C. Druskin et al.
BJU INTERNATIONAL (2018)
The Stockholm-3 Model for Prostate Cancer Detection: Algorithm Update, Biomarker Contribution, and Reflex Test Potential
Peter Strom et al.
EUROPEAN UROLOGY (2018)
Reduction of two histone marks, H3k9me3 and H3k27me3 by epidrug induces neuroendocrine differentiation in prostate cancer
Eunsohl Lee et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2018)
Circulating Tumor DNA Genomics Correlate with Resistance to Abiraterone and Enzalutamide in Prostate Cancer
Matti Annala et al.
CANCER DISCOVERY (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Prospective Adaptive Utility Trial to Validate Performance of a Novel Urine Exosome Gene Expression Assay to Predict High-grade Prostate Cancer in Patients with Prostate-specific Antigen 2-10 ng/ml at Initial Biopsy
James McKiernan et al.
EUROPEAN UROLOGY (2018)
Urinary markers aiding in the detection and risk stratification of prostate cancer
Nicholas Raja et al.
TRANSLATIONAL ANDROLOGY AND UROLOGY (2018)
Extended Mortality Results for Prostate Cancer Screening in the PLCO Trial With Median Follow-Up of 15 Years
Paul F. Pinsky et al.
CANCER (2017)
Design-corrected variation by centre in mortality reduction in the ERSPC randomised prostate cancer screening trial
Matti Hakama et al.
JOURNAL OF MEDICAL SCREENING (2017)
EXPRESSION OF HMGB1 IN PROSTATE CANCER: CLINICAL AND BIOLOGICAL CORRELATIONS
Yong Hyun Park et al.
JOURNAL OF UROLOGY (2017)
MICHIGAN PROSTATE SCORE (MIPS): AN ANALYSIS OF A NOVEL URINARY BIOMARKER PANEL FOR THE PREDICTION OF PROSTATE CANCER AND ITS IMPACT ON BIOPSY RATES
Amir H. Lebastchi et al.
JOURNAL OF UROLOGY (2017)
miRNAs associated with prostate cancer risk and progression
Hung N. Luu et al.
BMC UROLOGY (2017)
Immunotherapy as a Promising Treatment for Prostate Cancer: A Systematic Review
Marlena Janiczek et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2017)
Circulating Nucleosomes and Nucleosome Modifications as Biomarkers in Cancer
Peter McAnena et al.
CANCERS (2017)
Prostate Health Index density improves detection of clinically significant prostate cancer
Jeffrey J. Tosoian et al.
BJU INTERNATIONAL (2017)
Biomarkers in prostate cancer - Current clinical utility and future perspectives
Alexander Kretschmer et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2017)
Androgen receptor gene status in plasma DNA associates with worse outcome on enzalutamide or abiraterone for castration-resistant prostate cancer: a multi-institution correlative biomarker study
V. Conteduca et al.
ANNALS OF ONCOLOGY (2017)
Prostate cancer risk prediction using the novel versions of the European Randomised Study for Screening of Prostate Cancer (ERSPC) and Prostate Cancer Prevention Trial (PCPT) risk calculators: independent validation and comparison in a contemporary European cohort
Cedric Poyet et al.
BJU INTERNATIONAL (2016)
Urine TMPRSS2:ERG Plus PCA3 for Individualized Prostate Cancer Risk Assessment
Scott A. Tomlins et al.
EUROPEAN UROLOGY (2016)
Detection of High-grade Prostate Cancer Using a Urinary Molecular Biomarker-Based Risk Score
Leander Van Neste et al.
EUROPEAN UROLOGY (2016)
Tissue-based Genomics Augments Post-prostatectomy Risk Stratification in a Natural History Cohort of Intermediate- and High-Risk Men
Ashley E. Ross et al.
EUROPEAN UROLOGY (2016)
Impact of the Cell Cycle Progression Test on Physician and Patient Treatment Selection for Localized Prostate Cancer
Neal D. Shore et al.
JOURNAL OF UROLOGY (2016)
KAT8 Regulates Androgen Signaling in Prostate Cancer Cells
Ji-Young Kim et al.
MOLECULAR ENDOCRINOLOGY (2016)
Risk score predicts high-grade prostate cancer in DNA-methylation positive, histopathologically negative biopsies
Leander Van Neste et al.
PROSTATE (2016)
Decipher correlation patterns post prostatectomy: initial experience from 2342 prospective patients
R. B. Den et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2016)
4-Kallikrein Test and Kallikrein Markers in Prostate Cancer Screening
Michelle L. McDonald et al.
UROLOGIC CLINICS OF NORTH AMERICA (2016)
Histone Modifications and Cancer
James E. Audia et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2016)
A Novel Urine Exosome Gene Expression Assay to Predict High-grade Prostate Cancer at Initial Biopsy
James McKiernan et al.
JAMA ONCOLOGY (2016)
From Inflammation to Prostate Cancer: The Role of Inflammasomes
Dev Karan et al.
ADVANCES IN UROLOGY (2016)
Validation of an RNA cell cycle progression score for predicting death from prostate cancer in a conservatively managed needle biopsy cohort
J. Cuzick et al.
BRITISH JOURNAL OF CANCER (2015)
Identification of a Candidate Gene Panel for the Early Diagnosis of Prostate Cancer
Gisele H. J. M. Leyten et al.
CLINICAL CANCER RESEARCH (2015)
Development and Clinical Validation of an In Situ Biopsy-Based Multimarker Assay for Risk Stratification in Prostate Cancer
Peter Blume-Jensen et al.
CLINICAL CANCER RESEARCH (2015)
Recent trends in incidence of five common cancers in 26 European countries since 1988: Analysis of the European Cancer Observatory
Melina Arnold et al.
EUROPEAN JOURNAL OF CANCER (2015)
A Multi-institutional Prospective Trial in the USA Confirms that the 4Kscore Accurately Identifies Men with High-grade Prostate Cancer
Dipen J. Parekh et al.
EUROPEAN UROLOGY (2015)
Improving the Specificity of Screening for Lethal Prostate Cancer Using Prostate-specific Antigen and a Panel of Kallikrein Markers: A Nested Case-Control Study
Par Stattin et al.
EUROPEAN UROLOGY (2015)
Characterization of 1577 Primary Prostate Cancers Reveals Novel Biological and Clinicopathologic Insights into Molecular Subtypes
Scott A. Tomlins et al.
EUROPEAN UROLOGY (2015)
Predicting prostate cancer: analysing the clinical efficacy of prostate cancer risk calculators in a referral population
R. W. Foley et al.
IRISH JOURNAL OF MEDICAL SCIENCE (2015)
Prostate cancer screening in men aged 50-69 years (STHLM3): a prospective population-based diagnostic study
Henrik Gronberg et al.
LANCET ONCOLOGY (2015)
Plasma AR and abiraterone-resistant prostate cancer
Alessandro Romanel et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
SMYD3 contributes to a more aggressive phenotype of prostate cancer and targets Cyclin D2 through H4K20me3
Filipa Quintela Vieira et al.
ONCOTARGET (2015)
Circulating HMGB1 and RAGE as Clinical Biomarkers in Malignant and Autoimmune Diseases
Christin Pilzweger et al.
DIAGNOSTICS (2015)
Identification of proteomic biomarkers predicting prostate cancer aggressiveness and lethality despite biopsy-sampling error
M. Shipitsin et al.
BRITISH JOURNAL OF CANCER (2014)
Histone H2A.Z deregulation in prostate cancer. Cause or effect?
Deanna Dryhurst et al.
CANCER AND METASTASIS REVIEWS (2014)
Epigenetic biomarkers in prostate cancer: Current and future uses
Karen Chiam et al.
CANCER LETTERS (2014)
DNA damage and repair markers (H2AX and RAD51) improve accuracy of prostate cancer diagnosis and improve identification of aggressive disease
Amit M. Algotar et al.
CANCER RESEARCH (2014)
Influence of a genomic classifier on post-operative treatment decisions in high-risk prostate cancer patients: results from the PRO-ACT study
Steven N. Michalopoulos et al.
CURRENT MEDICAL RESEARCH AND OPINION (2014)
A 17-gene Assay to Predict Prostate Cancer Aggressiveness in the Context of Gleason Grade Heterogeneity, Tumor Multifocality, and Biopsy Undersampling
Eric A. Klein et al.
EUROPEAN UROLOGY (2014)
Prospective Multicentre Evaluation of PCA3 and TMPRSS2-ERG Gene Fusions as Diagnostic and Prognostic Urinary Biomarkers for Prostate Cancer
Gisele H. J. M. Leyten et al.
EUROPEAN UROLOGY (2014)
Can Urinary PCA3 Supplement PSA in the Early Detection of Prostate Cancer?
John T. Wei et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Expression and functionality of histone H2A variants in cancer
Fatima Liliana Monteiro et al.
ONCOTARGET (2014)
Clinical performance of serum prostate-specific antigen isoform [-2]proPSA (p2PSA) and its derivatives, %p2PSA and the prostate health index (PHI), in men with a family history of prostate cancer: results from a multicentre European study, the PROMEtheuS project
Massimo Lazzeri et al.
BJU INTERNATIONAL (2013)
Analytical validation of the Oncotype DX prostate cancer assay - a clinical RT-PCR assay optimized for prostate needle biopsies
Dejan Knezevic et al.
BMC GENOMICS (2013)
Multicenter Evaluation of [-2]Proprostate-Specific Antigen and the Prostate Health Index for Detecting Prostate Cancer
Carsten Stephan et al.
CLINICAL CHEMISTRY (2013)
Evaluation of [-2] proPSA and Prostate Health Index (phi) for the detection of prostate cancer: a systematic review and meta-analysis
Xavier Filella et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2013)
Prognostic Utility of Cell Cycle Progression Score in Men With Prostate Cancer After Primary External Beam Radiation Therapy
Stephen J. Freedland et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2013)
Early Detection of Prostate Cancer: AUA Guideline
H. Ballentine Carter et al.
JOURNAL OF UROLOGY (2013)
Discovery and Validation of a Prostate Cancer Genomic Classifier that Predicts Early Metastasis Following Radical Prostatectomy
Nicholas Erho et al.
PLOS ONE (2013)
Diagnostic significance of [-2]pro-PSA and prostate dimension-adjusted PSA-related indices in men with total PSA in the 2.0-10.0 ng/mL range
Kazuto Ito et al.
WORLD JOURNAL OF UROLOGY (2013)
The TMPRSS2:ERG Rearrangement, ERG Expression, and Prostate Cancer Outcomes: A Cohort Study and Meta-analysis
Andreas Pettersson et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2012)
RKI-1447 Is a Potent Inhibitor of the Rho-Associated ROCK Kinases with Anti-Invasive and Antitumor Activities in Breast Cancer
Ronil A. Patel et al.
CANCER RESEARCH (2012)
Preoperative Prostate-Specific Antigen Isoform p2PSA and Its Derivatives, %p2PSA and Prostate Health Index, Predict Pathologic Outcomes in Patients Undergoing Radical Prostatectomy for Prostate Cancer
Giorgio Guazzoni et al.
EUROPEAN UROLOGY (2012)
Active Surveillance for Prostate Cancer: A Systematic Review of the Literature
Marc A. Dall'Era et al.
EUROPEAN UROLOGY (2012)
Diagnostic Performance of PCA3 to Detect Prostate Cancer in Men with Increased Prostate Specific Antigen: A Prospective Study of 1,962 Cases
E. David Crawford et al.
JOURNAL OF UROLOGY (2012)
Histone Methyltransferase NSD2/MMSET Mediates Constitutive NF-κB Signaling for Cancer Cell Proliferation, Survival, and Tumor Growth via a Feed-Forward Loop
Ping Yang et al.
MOLECULAR AND CELLULAR BIOLOGY (2012)
Can the prostate risk calculator based on western population be applied to asian population?
Duck Ki Yoon et al.
PROSTATE (2012)
A tissue biopsy-based epigenetic multiplex PCR assay for prostate cancer detection
Leander Van Neste et al.
BMC UROLOGY (2012)
Comparison of risk calculators from the Prostate Cancer Prevention Trial and the European Randomized Study of Screening for Prostate Cancer in a contemporary Canadian cohort
Greg Trottier et al.
BJU INTERNATIONAL (2011)
Prediction of prostate cancer in unscreened men: External validation of a risk calculator
Heidi A. van Vugt et al.
EUROPEAN JOURNAL OF CANCER (2011)
Epigenetics in Prostate Cancer: Biologic and Clinical Relevance
Carmen Jeronimo et al.
EUROPEAN UROLOGY (2011)
Contemporary Role of Prostate Cancer Antigen 3 in the Management of Prostate Cancer
Marco Auprich et al.
EUROPEAN UROLOGY (2011)
Prostate Cancer Antigen 3 Score Accurately Predicts Tumour Volume and Might Help in Selecting Prostate Cancer Patients for Active Surveillance
Guillaume Ploussard et al.
EUROPEAN UROLOGY (2011)
A Multicenter Study of [-2]Pro-Prostate Specific Antigen Combined With Prostate Specific Antigen and Free Prostate Specific Antigen for Prostate Cancer Detection in the 2.0 to 10.0 ng/ml Prostate Specific Antigen Range
William J. Catalona et al.
JOURNAL OF UROLOGY (2011)
Clinical Evaluation of the PCA3 Assay in Guiding Initial Biopsy Decisions
Alexandre de la Taille et al.
JOURNAL OF UROLOGY (2011)
Prognostic value of an RNA expression signature derived from cell cycle proliferation genes in patients with prostate cancer: a retrospective study
Jack Cuzick et al.
LANCET ONCOLOGY (2011)
HMGB1 and RAGE in Inflammation and Cancer
Gary P. Sims et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 28 (2010)
Application of histone modification in the risk prediction of the biochemical recurrence after radical prostatectomy
Li-Xin Zhou et al.
ASIAN JOURNAL OF ANDROLOGY (2010)
The relationship of prostate-specific antigen to digital rectal examination and transrectal ultrasonography: Findings of the American cancer society national prostate cancer detection project
R. Joseph Babaian et al.
CANCER (2010)
A Prospective, Multicenter, National Cancer Institute Early Detection Research Network Study of [-2]proPSA: Improving Prostate Cancer Detection and Correlating with Cancer Aggressiveness
Lori J. Sokoll et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2010)
A Four-Kallikrein Panel Predicts Prostate Cancer in Men with Recent Screening: Data from the European Randomized Study of Screening for Prostate Cancer, Rotterdam
Andrew J. Vickers et al.
CLINICAL CANCER RESEARCH (2010)
Prostate-Specific Antigen (PSA) Isoform p2PSA in Combination with Total PSA and Free PSA Improves Diagnostic Accuracy in Prostate Cancer Detection
Flip H. Jansen et al.
EUROPEAN UROLOGY (2010)
Prostate Cancer Prevention Trial and European Randomized Study of Screening for Prostate Cancer Risk Calculators: A Performance Comparison in a Contemporary Screened Cohort
Vitor Cavadas et al.
EUROPEAN UROLOGY (2010)
Reducing Unnecessary Biopsy During Prostate Cancer Screening Using a Four-Kallikrein Panel: An Independent Replication
Andrew Vickers et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
[-2]Proenzyme Prostate Specific Antigen is More Accurate Than Total and Free Prostate Specific Antigen in Differentiating Prostate Cancer From Benign Disease in a Prospective Prostate Cancer Screening Study
Brian V. Le et al.
JOURNAL OF UROLOGY (2010)
Global Levels of Histone Modifications Predict Prostate Cancer Recurrence
Joerg Ellinger et al.
PROSTATE (2010)
Histone modifications and chromatin organization in prostate cancer
Zhong Chen et al.
EPIGENOMICS (2010)
A [-2]proPSA-Based Artificial Neural Network Significantly Improves Differentiation Between Prostate Cancer and Benign Prostatic Diseases
Carsten Stephan et al.
PROSTATE (2009)
A panel of kallikrein markers can reduce unnecessary biopsy for prostate cancer: data from the European Randomized Study of Prostate Cancer Screening in Goteborg, Sweden
Andrew J. Vickers et al.
BMC MEDICINE (2008)
Circulating Tumor Cells Predict Survival Benefit from Treatment in Metastatic Castration-Resistant Prostate Cancer
Johann S. de Bono et al.
CLINICAL CANCER RESEARCH (2008)
Clinical Utility of the PCA3 Urine Assay in European Men Scheduled for Repeat Biopsy
Alexander Haese et al.
EUROPEAN UROLOGY (2008)
Prostate-specific antigen and prostate cancer: prediction, detection and monitoring
Hans Lilja et al.
NATURE REVIEWS CANCER (2008)
Circulating tumor cell number and prognosis in progressive castration-resistant prostate cancer
Daniel C. Danila et al.
CLINICAL CANCER RESEARCH (2007)
PCA3 molecular urine assay for prostate cancer in men undergoing repeat biopsy
Leonard S. Marks et al.
UROLOGY (2007)
Prediction of indolent prostate cancer: Validation and updating of a prognostic nomogram
E. W. Steyerberg et al.
JOURNAL OF UROLOGY (2007)
Receptor for advanced glycation end products (RAGE) and its ligand, amphoterin are overexpressed and associated with prostate cancer development
H Ishiguro et al.
PROSTATE (2005)
Proenzyme forms of prostate-specific antigen in serum improve the detection of prostate cancer
SD Mikolajczyk et al.
CLINICAL CHEMISTRY (2004)
PSA markers in prostate cancer detection
MB Gretzer et al.
UROLOGIC CLINICS OF NORTH AMERICA (2003)
The polycomb group protein EZH2 is involved in progression of prostate cancer
S Varambally et al.
NATURE (2002)
Free prostate-specific antigen in serum is becoming more complex
SD Mikolajczyk et al.
UROLOGY (2002)
DNA alterations in body fluids as molecular tumor markers for urological malignancies
C Goessl et al.
EUROPEAN UROLOGY (2002)
分享论文
